FIELD: medicine, gynecology. SUBSTANCE: method involves administration of hormonal preparations and immune state normalization. Dalargin is administrated by the following scheme: 0.001 g intramuscularly, once per 24 h for 10 days at the 2-d phase of menstrual cycle for 3 months, 2 course per year at 6 months interval. EFFECT: enhanced effectiveness of treatment, decreased relapses and treatment period.
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DIAGNOSTICS OF MINOR FORMS OF ENDOMETRIOSIS | 2020 |
|
RU2749290C1 |
| METHOD FOR DIAGNOSING VASCULAR DISORDERS IN PREGNANT WOMEN AT EARLY DEVELOPMENT STAGE OF PATHOLOGIC GESTATION COURSE | 1994 |
|
RU2061960C1 |
| METHOD OF TREATMENT OF PATIENTS ILL WITH ENDOMETRIOSIS | 0 |
|
SU1113113A1 |
| METHOD FOR TREATING STERILITY IN WOMEN WITH EXTERNAL GENITAL ENDOMETRIOSIS | 2004 |
|
RU2253489C1 |
| METHOD TO TREAT GENITAL ENDOMETRIOSIS | 1993 |
|
RU2073534C1 |
| METHOD OF TREATING EXTERNAL GENITAL ENDOMETRIOSIS | 2018 |
|
RU2693050C1 |
| METHOD FOR TREATMENT OF ENDOMETRIOSIS AND PREVENTION OF ITS RELAPSES | 2022 |
|
RU2787090C1 |
| METHOD OF TREATING EXTERNAL GENITAL ENDOMETRIOSIS | 2019 |
|
RU2732251C1 |
| METHOD OF TREATING EXTERNAL GENITAL ENDOMETRIOSIS | 2019 |
|
RU2727299C1 |
| METHOD OF TREATING ENDOMETRIOSIS | 2011 |
|
RU2493808C2 |
